Recent evidence highlighted, in some cancer models (e.g., breast cancer), the role of the PVT1 promoter in the transcriptional regulation of MYC. In detail, Cho et al. identified four PVT1-intergenic enhancers increasing MYC expression when the PVT1 promoter is inactive. Here, PVT1 is linked to breast cancer.